市場調查報告書

緩釋性藥物輸送的市場規模·佔有率·趨勢分析:2020年∼2027年的預測

Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report By Technology (Micro Encapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 640052
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
緩釋性藥物輸送的市場規模·佔有率·趨勢分析:2020年∼2027年的預測 Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report By Technology (Micro Encapsulation, Targeted Delivery), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年03月04日內容資訊: 英文 120 Pages
簡介

全球緩釋性藥物輸送的市場規模在2020年∼2027年間,預測將以7.8%的年複合成長率擴大,2027年達到698億美元的規模。治療效果的提高,副作用的減輕,治療費的削減等緩釋性藥物遞輸系統相關的優點成為帶動市場成長的要素。

與傳統的遞送形式相比,該技術降低了劑量及給藥頻率,提高患者配合度,降低消化道的副作用,療效均勻,提高藥效及安全性,及降低血漿中藥物濃度的變動等各種優點

本報告提供全球緩釋性藥物輸送市場相關調查,彙整市場趨勢與2027年為止的預測,各市場區隔趨勢,各地區趨勢,參與企業的簡介等資訊。

目錄

第1章 調查手法和範圍

  • 市場區隔和範圍
  • 調查手法
  • 資訊採購
  • 資訊·資料分析
  • 市場形成與檢驗
  • 模式詳細內容
  • 二級資訊來源的清單
  • 主要的資訊來源的清單
  • 目的

第2章 摘要整理

第3章 緩釋性藥物輸送市場變數,趨勢,範圍

  • 市場預測
  • 普及率和成長預測
  • 產業的價值鏈分析
  • 市場動態
  • 市場分析工具

第4章 全球緩釋性藥物輸送市場:各技術的預測與趨勢分析

  • 定義和範圍
    • Wurster技術
    • 凝聚
    • 微膠囊化
    • 植入
    • 經皮給藥
    • 標的給藥
    • 其他
  • 市場佔有率
  • 市場區隔儀表板
  • 全球緩釋性藥物輸送市場:各技術
  • 市場規模,預測及趨勢分析

第5章 全球緩釋性藥物輸送市場:各放出機制的預測與趨勢分析

  • 定義和範圍
    • 聚合物為基礎的系統
    • 微reservoir分區緩釋性藥物遞輸系統
    • 回饋法規藥物遞輸系統
    • 活性化調節藥物遞輸系統
    • 化學的活性化緩釋性藥物遞輸系統
  • 市場佔有率
  • 市場區隔儀表板
  • 全球緩釋性藥物輸送市場:各放出機制
  • 市場規模,預測及趨勢分析

第6章 全球緩釋性藥物輸送市場:各用途的預測與趨勢分析

  • 定義和範圍
    • 定量吸入器
    • 注射劑
    • 經皮及眼貼
    • 輸液幫浦
    • 口服控製藥物遞輸系統
    • 藥劑溶出性血管支架
  • 市場佔有率
  • 市場區隔儀表板
  • 全球緩釋性藥物輸送市場:各用途
  • 市場規模,預測及趨勢分析

第7章 全球緩釋性藥物輸送市場:不同地區的預測與趨勢分析

  • 市場佔有率分析
  • 市場儀表板
  • 各地區市場的概述
  • 市場佔有率和主要企業
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • SWOT分析
  • 市場規模與預測,數量,趨勢分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 瑞士
    • 荷蘭
    • 瑞典
    • 比利時
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 印尼
    • 菲律賓
    • 越南
    • 馬來西亞
    • 新加坡
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 其他
  • 中東·非洲地區
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 以色列
    • 其他

第8章 競爭情形

  • Recent Developments & Impact Analysis, By Key Market Participants
  • Company/Competition Categorization
  • Vendor Landscape
  • Public Companies
  • Private Companies

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-2-68038-347-8

The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.

These technologies offer various benefits over traditional delivery forms, such as reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels.

Presence of multiple in-vivo biological barriers that affects the absorption, bioavailability, and stability of the drug has open wide horizon for the controlled release drug delivery products. For instance, controlled release drug delivery system has enabled delivery of even large and complex molecules such as DNA/RNA, proteins and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.

Rapidly increasing geriatric and pediatric population is one of the major factors fueling the demand for controlled release drug delivery systems, due to high cases prescription non-adherence in this age-group. Innovations in various drug delivery systems has been providing geriatric and pediatric population with easy solutions, which are further propelling the market. Controlled release of drug delivery systems can be altered according to required dosage over a specific period of time.

Further key findings from the report suggest:

Based on application, oral controlled release systems held the largest market share in 2019 owing to increasing usage and ease of convenience offered for administration of medication

Targeted drug delivery is poised to be the fastest growing technology segment during the forecast period owing to various benefits of the technology, such as increased safety and therapeutic efficacy

Osmotic delivery is projected to witness the fastest CAGR in the activation modulation drug delivery systems during the forecast period, due to the ability of this release mechanism to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility

North America held the largest market share in 2019 owing to the presence of developed healthcare infrastructure facilities, increasing R&D activities and existence of major market players

Asia Pacific is expected to post the highest CAGR during the forecast period owing to rising investments by dominant players in the region along with developments in the of pharmaceutical industry in emerging countries, such as India and China

Some of the prominent companies operating in the controlled release drug delivery market are Orbis Biosciences, Inc.; Merck and Co., Inc.; Alkermes plc; Johnson and Johnson; Coating Place, Inc.; Corium International, Inc.; Depomed, Inc.; Pfizer, Inc; Aradigm Corporation; and Capsugel

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Release mechanism
    • 1.1.3. Application
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Release mechanism outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Controlled release drug delivery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric population
      • 3.4.1.2. Increased compliance due to nature of dosage forms
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Limited amount of controlled release dosage forms is acceptable for usage in pediatric conditions
      • 3.4.2.2. Need for high dose of active pharmaceutical ingredient
  • 3.5. Controlled Release Drug Delivery Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Global controlled release drug delivery Market: Technology Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Wurster technique
    • 4.1.2. Coacervation
    • 4.1.3. Micro encapsulation
    • 4.1.4. Implants
    • 4.1.5. Transdermal
    • 4.1.6. Targeted delivery
    • 4.1.7. Others
  • 4.2. controlled release drug delivery Market Share, 2019 & 2027
  • 4.3. Segment Dashboard
  • 4.4. Global controlled release drug delivery Market by Technology Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 4.5.1. Wurster technique
      • 4.5.1.1. Wurster technique controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 4.5.2. Coacervation
      • 4.5.2.1. Coacervation controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 4.5.3. Micro Encapsulation
      • 4.5.3.1. Micro encapsulation controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 4.5.4. Implants
      • 4.5.4.1. Implants controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 4.5.5. Transdermal
      • 4.5.5.1. Transdermal controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 4.5.6. Targeted delivery
      • 4.5.6.1. Targeted delivery controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others controlled release drug delivery market, 2016 - 2027 (USD Million)

Chapter 5. Global controlled release drug delivery Market: Release Mechanism Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Polymer Based Systems
    • 5.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
    • 5.1.3. Feedback Regulated Drug Delivery Systems
    • 5.1.4. Activation-modulated Drug Delivery Systems
      • 5.1.4.1. Osmotic Pressure Activated
      • 5.1.4.2. Hydrodynamic Pressure Activated
      • 5.1.4.3. Vapor Pressure Activated
      • 5.1.4.4. Mechanically Activated
      • 5.1.4.5. Magnetically Activated
    • 5.1.5. Chemically Activated
      • 5.1.5.1. pH Activated
      • 5.1.5.2. Hydrolysis Activated
      • 5.1.5.3. Enzyme Activated
  • 5.2. controlled release drug delivery Market Share, 2019 & 2027
  • 5.3. Segment Dashboard
  • 5.4. Global controlled release drug delivery Market by Release Mechanism Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 5.5.1. Polymer based systems
      • 5.5.1.1. Polymer based systems controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 5.5.2. Micro reservoir partition controlled drug delivery systems
      • 5.5.2.1. Micro reservoir partition controlled drug delivery systems market, 2016 - 2027 (USD Million)
    • 5.5.3. Feedback regulated drug delivery systems
      • 5.5.3.1. Feedback regulated drug delivery systems market, 2016 - 2027 (USD Million)
    • 5.5.4. Activation-modulated drug delivery systems
      • 5.5.4.1. Activation-modulated drug delivery systems market, 2016 - 2027 (USD Million)
      • 5.5.4.2. Osmotic pressure activated systems market, 2016 - 2027 (USD Million)
      • 5.5.4.3. Hydrodynamic pressure activated systems market, 2016 - 2027 (USD Million)
      • 5.5.4.4. Vapor pressure activated systems market, 2016 - 2027 (USD Million)
      • 5.5.4.5. Mechanically activated systems market, 2016 - 2027 (USD Million)
      • 5.5.4.6. Magnetically activated systems market, 2016 - 2027 (USD Million)
    • 5.5.5. Chemically activated
      • 5.5.5.1. pH activated controlled release drug delivery market, 2016 - 2027 (USD Million)
      • 5.5.5.2. Hydrolysis activated controlled release drug delivery market, 2016 - 2027 (USD Million)
      • 5.5.5.3. Enzyme activated controlled release drug delivery market, 2016 - 2027 (USD Million)

Chapter 6. Global controlled release drug delivery Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Metered Dose Inhalers
    • 6.1.2. Injectable
    • 6.1.3. Transdermal and Ocular Patches
    • 6.1.4. Infusion Pumps
    • 6.1.5. Oral Controlled-drug delivery Systems
    • 6.1.6. Drug Eluting Stents
  • 6.2. controlled release drug delivery Market Share, 2019 & 2027
  • 6.3. Segment Dashboard
  • 6.4. Global controlled release drug delivery Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 6.5.1. Metered dose inhalers
      • 6.5.1.1. Metered dose inhaler controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 6.5.2. Injectable
      • 6.5.2.1. Injectable controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 6.5.3. Transdermal and ocular patches
      • 6.5.3.1. Transdermal and ocular patches controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 6.5.4. Infusion Pumps
      • 6.5.4.1. Infusion pumps controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 6.5.5. Oral controlled release drug delivery system
      • 6.5.5.1. Oral controlled release drug delivery market, 2016 - 2027 (USD Million)
    • 6.5.6. Drug eluting stents
      • 6.5.6.1. Drug eluting stents controlled release drug delivery market, 2016 - 2027 (USD Million)

Chapter 7. Global controlled release drug delivery Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2019 & 2027
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2019
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.8. Europe
    • 7.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.2. U.K.
      • 7.8.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.3. Germany
      • 7.8.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.4. France
      • 7.8.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.5. Italy
      • 7.8.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.6. Spain
      • 7.8.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.7. Russia
      • 7.8.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.8. Switzerland
      • 7.8.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.9. The Netherland
      • 7.8.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.10. Sweden
      • 7.8.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.11. Belgium
      • 7.8.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.12. Others
      • 7.8.12.1. Market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.2. Japan
      • 7.9.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.3. China
      • 7.9.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.4. India
      • 7.9.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.5. South Korea
      • 7.9.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.6. Thailand
      • 7.9.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.7. Indonesia
      • 7.9.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.8. Philippines
      • 7.9.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.9. Vietnam
      • 7.9.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.10. Malaysia
      • 7.9.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.11. Singapore
      • 7.9.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.12. Others
      • 7.9.12.1. Market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.10. Latin America
    • 7.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.2. Brazil
      • 7.10.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.3. Mexico
      • 7.10.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.4. Argentina
      • 7.10.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.5. Colombia
      • 7.10.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.6. Chile
      • 7.10.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.7. Others
      • 7.10.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.11. MEA
    • 7.11.1. South Africa
      • 7.11.1.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.11.3. UAE
      • 7.11.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.11.4. Kuwait
      • 7.11.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.11.5. Israel
      • 7.11.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.11.6. Others
      • 7.11.6.1. Market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
    • 8.2.2. Market Leaders
    • 8.2.3. Emerging Players
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2019
  • 8.4. Public Companies
    • 8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 8.4.2. Company market share/ranking, by region
    • 8.4.3. Competitive dashboard analysis
      • 8.4.3.1. Market differentiators
      • 8.4.3.2. Synergy analysis: major deals and strategic alliances
  • 8.5. Private Companies
    • 8.5.1. List of key emerging companies/technology disruptors/innovators
    • 8.5.2. Funding outlook
    • 8.5.3. Regional network map
    • 8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
    • 8.5.5. Supplier ranking
    • 8.5.6. Key company profiled
    • 8.5.7. Depomed, Inc.
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Coating Place, Inc.
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Corium International, Inc.
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Johnson and Johnson Services, Inc.
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic Initiative
    • 8.5.11. Alkermes plc
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Pfizer, Inc.
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Orbis Biosciences, Inc.
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Capsugel
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Merck and Co., Inc.
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Aradigm Corporation
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product benchmarking
      • 8.5.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
  • Table 3 North America controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 4 North America controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 5 North America controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 6 U.S. controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 7 U.S. controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 8 U.S. controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 9 Canada controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 10 Canada controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 11 Canada controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 12 Europe controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
  • Table 13 Europe controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 14 Europe controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 15 Europe controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 16 Germany controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 17 Germany controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 18 Germany controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 19 U.K. controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 20 U.K. controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 21 U.K. controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 22 France controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 23 France controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 24 France controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 25 Italy controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 26 Italy controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 27 Italy controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 28 Spain controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 29 Spain controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 30 Spain controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 31 The Netherland controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 32 The Netherland controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 33 The Netherland controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 34 Switzerland controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 35 Switzerland controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 36 Switzerland controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 37 Russia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 38 Russia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 39 Russia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 40 Sweden controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 41 Sweden controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 42 Sweden controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 43 Belgium controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 44 Belgium controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 45 Belgium controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 46 Asia Pacific controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
  • Table 47 Asia Pacific controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 48 Asia Pacific controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 49 Asia Pacific controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 50 Japan controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 51 Japan controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 52 Japan controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 53 China controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 54 China controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 55 China controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 56 India controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 57 India controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 58 India controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 59 South Korea controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 60 South Korea controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 61 South Korea controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 62 Thailand controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 63 Thailand controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 64 Thailand controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 65 Indonesia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 66 Indonesia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 67 Indonesia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 68 Philippines controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 69 Philippines controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 70 Philippines controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 71 Vietnam controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 72 Vietnam controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 73 Vietnam controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 74 Singapore controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 75 Singapore controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 76 Singapore controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 77 Malaysia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 78 Malaysia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 79 Malaysia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 80 Latin America controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
  • Table 81 Latin America controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 82 Latin America controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 83 Latin America controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 84 Brazil controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 85 Brazil controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 86 Brazil controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 87 Mexico controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 88 Mexico controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 89 Mexico controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 90 Argentina controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 91 Argentina controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 92 Argentina controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 93 Colombia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 94 Colombia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 95 Colombia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 96 Chile controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 97 Chile controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 98 Chile controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 99 Middle east and Africa controlled release drug delivery market, by region, 2016 - 2027 (USD Million)
  • Table 100 Middle east and Africa controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 101 Middle east and Africa controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 102 Middle east and Africa controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 103 South Africa controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 104 South Africa controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 105 South Africa controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 106 Saudi Arabia controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 107 Saudi Arabia controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 108 Saudi Arabia controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 109 UAE controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 110 UAE controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 111 UAE controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 112 Kuwait controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 113 Kuwait controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 114 Kuwait controlled release drug delivery market, by application, 2016 - 2027 (USD Million)
  • Table 115 Israel controlled release drug delivery market, by technology, 2016 - 2027 (USD Million)
  • Table 116 Israel controlled release drug delivery market, by release mechanism, 2016 - 2027 (USD Million)
  • Table 117 Israel controlled release drug delivery market, by application, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 controlled release drug delivery market: market outlook
  • Fig. 14 controlled release drug delivery market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 controlled release drug delivery market driver impact
  • Fig. 20 controlled release drug delivery market restraint impact
  • Fig. 21 controlled release drug delivery market strategic initiatives analysis
  • Fig. 22 controlled release drug delivery market: technology movement analysis
  • Fig. 23 controlled release drug delivery market: technology outlook and key takeaways
  • Fig. 24 Wurster technique market estimates and forecast, 2016 - 2027
  • Fig. 25 Coacervation market estimates and forecast, 2016 - 2027
  • Fig. 26 Micro encapsulation market estimates and forecast, 2016 - 2027
  • Fig. 27 Implants market estimates and forecast, 2016 - 2027
  • Fig. 28 Transdermal market estimates and forecast, 2016 - 2027
  • Fig. 29 Targeted delivery market estimates and forecast, 2016 - 2027
  • Fig. 30 Others market estimates and forecast, 2016 - 2027
  • Fig. 31 controlled release drug delivery market: release mechanism movement analysis
  • Fig. 32 controlled release drug delivery market: release mechanism outlook and key takeaways
  • Fig. 33 Polymer based systems market estimates and forecast, 2016 - 2027
  • Fig. 34 Micro reservoir partition-controlled drug delivery systems estimates and forecasts, 2016 - 2027
  • Fig. 35 Feedback regulate drug delivery systems estimates and forecasts, 2016 - 2027
  • Fig. 36 Activation-modulated drug delivery systems estimates and forecasts, 2016 - 2027
  • Fig. 37 Chemically activated drug delivery systems estimates and forecasts, 2016 - 2027
  • Fig. 38 controlled release drug delivery market: application movement analysis
  • Fig. 39 controlled release drug delivery market: application outlook and key takeaways
  • Fig. 40 Metered dose inhaler market estimates and forecasts, 2016 - 2027
  • Fig. 41 Injectable controlled release drug delivery market estimates and forecasts, 2016 - 2027
  • Fig. 42 Transdermal and Ocular patches controlled release drug delivery market estimates and forecasts, 2016 - 2027
  • Fig. 43 Infusion pumps controlled release drug delivery market estimates and forecasts, 2016 - 2027
  • Fig. 44 Oral controlled drug delivery systems market estimates and forecasts, 2016 - 2027
  • Fig. 45 Drug eluting stents controlled release drug delivery market estimates and forecasts, 2016 - 2027
  • Fig. 46 Global controlled release drug delivery market: regional movement analysis
  • Fig. 47 Global controlled release drug delivery market: regional outlook and key takeaways
  • Fig. 48 Global controlled release drug delivery market share and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America: SWOT
  • Fig. 55 Europe SWOT
  • Fig. 56 Asia Pacific SWOT
  • Fig. 57 Latin America SWOT
  • Fig. 58 MEA SWOT
  • Fig. 59 North America, by country
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecasts, 2016 - 2027
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecasts, 2016 - 2027
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecasts, 2016 - 2027
  • Fig. 66 Europe
  • Fig. 67 Europe. market estimates and forecasts, 2016 - 2027
  • Fig. 68 U.K.
  • Fig. 69 U.K. market estimates and forecasts, 2016 - 2027
  • Fig. 70 Germany
  • Fig. 71 Germany market estimates and forecasts, 2016 - 2027
  • Fig. 72 France
  • Fig. 73 France market estimates and forecasts, 2016 - 2027
  • Fig. 74 Italy
  • Fig. 75 Italy market estimates and forecasts, 2016 - 2027
  • Fig. 76 Spain
  • Fig. 77 Spain market estimates and forecasts, 2016 - 2027
  • Fig. 78 Russia
  • Fig. 79 Russia market estimates and forecasts, 2016 - 2027
  • Fig. 80 The Netherlands
  • Fig. 81 The Netherlands market estimates and forecasts, 2016 - 2027
  • Fig. 82 Switzerland
  • Fig. 83 Switzerland market estimates and forecasts, 2016 - 2027
  • Fig. 84 Sweden
  • Fig. 85 Sweden market estimates and forecasts, 2016 - 2027
  • Fig. 86 Belgium
  • Fig. 87 Belgium market estimates and forecasts, 2016 - 2027
  • Fig. 88 Asia Pacific
  • Fig. 89 Asia Pacific market estimates and forecasts, 2016 - 2027
  • Fig. 90 China
  • Fig. 91 China market estimates and forecasts, 2016 - 2027
  • Fig. 92 Japan
  • Fig. 93 Japan market estimates and forecasts, 2016 - 2027
  • Fig. 94 India
  • Fig. 95 India market estimates and forecasts, 2016 - 2027
  • Fig. 96 Thailand
  • Fig. 97 Thailand. market estimates and forecasts, 2016 - 2027
  • Fig. 98 South Korea
  • Fig. 99 South Korea market estimates and forecasts, 2016 - 2027
  • Fig. 100 Indonesia
  • Fig. 101 Indonesia market estimates and forecasts, 2016 - 2027
  • Fig. 102 Philippines
  • Fig. 103 Philippines market estimates and forecasts, 2016 - 2027
  • Fig. 104 Vietnam
  • Fig. 105 Vietnam market estimates and forecasts, 2016 - 2027
  • Fig. 106 Singapore
  • Fig. 107 Singapore market estimates and forecasts, 2016 - 2027
  • Fig. 108 Malaysia
  • Fig. 109 Malaysia market estimates and forecasts, 2016 - 2027
  • Fig. 110 Latin America
  • Fig. 111 Latin America market estimates and forecasts, 2016 - 2027
  • Fig. 112 Brazil
  • Fig. 113 Brazil market estimates and forecasts, 2016 - 2027
  • Fig. 114 Mexico
  • Fig. 115 Mexico market estimates and forecasts, 2016 - 2027
  • Fig. 116 Argentina
  • Fig. 117 Argentina market estimates and forecasts, 2016 - 2027
  • Fig. 118 Colombia
  • Fig. 119 Colombia market estimates and forecasts, 2016 - 2027
  • Fig. 120 Chile
  • Fig. 121 Chile market estimates and forecasts, 2016 - 2027
  • Fig. 122 Middle East and Africa
  • Fig. 123 Middle East and Africa. market estimates and forecasts, 2016 - 2027
  • Fig. 124 South Africa
  • Fig. 125 South Africa market estimates and forecasts, 2016 - 2027
  • Fig. 126 Saudi Arabia
  • Fig. 127 Saudi Arabia market estimates and forecasts, 2016 - 2027
  • Fig. 128 UAE
  • Fig. 129 UAE market estimates and forecasts, 2016 - 2027
  • Fig. 130 Kuwait
  • Fig. 131 Kuwait market estimates and forecasts, 2016 - 2027
  • Fig. 132 Israel
  • Fig. 133 Israel market estimates and forecasts, 2016 - 2027
  • Fig. 134 Participant categorization- controlled release drug delivery market
  • Fig. 135 Market share of key market players- controlled release drug delivery market